The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis
Abstract
OBJECTIVE: The aim of this study is to evaluate the clinical manifestation and prognostic factors of anti-melanoma differentiation-associated gene 5 (MDA5) antibody-associated interstitial lung disease (ILD) with DM. METHODS: Fourteen patients who presented with anti-MDA5 antibody and 10 patients with anti-aminoacyl-tRNA synthetase (ARS) antibody were enrolled. All patients were diagnosed as having DM with ILD. Clinical manifestations in the patients with anti-MDA5 antibody were compared with those in the patients with anti-ARS antibody. RESULTS: The frequencies of acute/subacute interstitial pneumonia (A/SIP) and fatal outcome were significantly higher in the subset with anti-MDA5 antibody. The creatine kinase (CK) value was significantly lower and the gamma-glutamyl transpeptidase and ferritin values were significantly higher in the subset with anti-MDA5 antibody. Significant correlations were found between PaO(2)/F(i)O(2) and ferritin (r(s) = -0.59, P = 0.035), alveolar-arterial oxygen difference (A-aDO(2)) and KL-6 (r(s) = 0.73, P = 0.016) and A-aDO(2) and ferritin (r(s) = 0.66, P = 0.013) in the subset with anti-MDA5 antibody. The most significant prognostic factor was ferritin. The cumulative survival rate was significantly lower (P < 0.0001) in the subset with ferritin >or=1600 ng/ml than that in the subset with ferritin <1600 ng/ml in anti-MDA5 antibody-associated ILD. CONCLUSION: Both serum ferritin and anti-MDA5 antibody are powerful indicators for the early diagnosis of A/SIP with DM. Ferritin also predicts disease severity and prognosis for patients with anti-MDA5 antibody. Intensive treatment should be administered to cases that have anti-MDA5 antibody-associated ILD with DM showing hyperferritinaemia, especially if the ferritin level is >or=1600 ng/ml.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
international consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Sato, S., Hirakata, M., Kuwana, M., Suwa, A., Inada, S., Mimori, T., Nishikawa, T., Oddis, C. V., & Ikeda, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21023 · Cited by 747
Self-citationSato, S., Hoshino, K., Satoh, T., Fujita, T., Kawakami, Y., Fujita, T., & Kuwana, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24621 · Cited by 604
Self-citationSontheimer, R. D. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120621 · Cited by 486
Interstitial lung disease in polymyositis and dermatomyositis
Marie, I., Hachulla, E., Chérin, P., Dominique, S., Hatron, P. ‐., Hellot, M. ‐., Devulder, B., Herson, S., Levesque, H., & Courtois, H. (2002) · Arthritis Care & Research · doi:10.1002/art.10794 · Cited by 478
Gerami, P., Schope, J. M., McDonald, L., Walling, H. W., & Sontheimer, R. D. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.041 · Cited by 455
Treatment of antisynthetase-associated interstitial lung disease with tacrolimus
Wilkes, M. R., Sereika, S. M., Fertig, N., Lucas, M. R., & Oddis, C. V. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21240 · Cited by 238
Cited by
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
Autoantibodies in Polymyositis and Dermatomyositis
Ghirardello, A., Bassi, N., Palma, L., Borella, E., Domeneghetti, M., Punzi, L., & Doria, A. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0335-1 · Cited by 461
Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
Gono, T., Sato, S., Kawaguchi, Y., Kuwana, M., Hanaoka, M., Katsumata, Y., Takagi, K., Baba, S., Okamoto, Y., Ota, Y., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes102 · Cited by 339
Self-citationChen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21985 · Cited by 288
Self-citation
Metadata
- Authors
- Gono, T., Kawaguchi, Y., Satoh, T., Kuwana, M., Katsumata, Y., Takagi, K., Masuda, I., Tochimoto, A., Baba, S., Okamoto, Y., Ota, Y., & Yamanaka, H.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-23
- Volume
- 49
- Issue
- 9
- Pages
- 1713-1719
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2168845228
- Cited by
- 319
- References
- 25
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. https://app.cochat.ai/papers/10.1093/rheumatology/keq149
- The paper
- Gono, T., Kawaguchi, Y., Satoh, T., Kuwana, M., Katsumata, Y., Takagi, K., Masuda, I., Tochimoto, A., Baba, S., Okamoto, Y., Ota, Y., & Yamanaka, H. (2010). Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology. https://doi.org/10.1093/rheumatology/keq149
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.